Trigg Leslie sold $15K of OM
Trigg Leslie (Chair and CEO) sold 3,437 shares of Outset Medical, Inc. (OM) at $4.39 on 2026-08-17.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale details by the Chair and CEO, including date, share count, price, and post-transaction holdings, with no pre-arranged 10b5-1 plan noted.
Market read
Traders may note insider selling without a 10b5-1 plan, but the transaction size and lack of fundamental updates make it unlikely to drive a sustained repricing.
What to watch
The filing does not state motivation, and the disclosed value ($15,088) is modest; without additional corroborating news, the signal-to-noise is low.
Background
This is an SEC Form 4 insider transaction disclosure for Outset Medical, Inc. (OM).
Ticker impact
Outset Medical CEO Trigg Leslie filed a Form 4 showing an open-market sale of 3,437 shares at $4.39 on 2026-08-17.
Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless paired with other disclosures.
Form 4 insider sales are common and this text provides no earnings, guidance, or operational change. The absence of a 10b5-1 plan can raise scrutiny, but the disclosed size ($15.1k) is small relative to typical market-moving thresholds.
Market effects
No sector-level implications; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
The sale could be unrelated to outlook (taxes, diversification, personal liquidity), so treating it as bearish may overfit to a small transaction.
Key entities
- issuerOutset Medical, Inc.
Company whose insider transaction was disclosed on Form 4.
- insiderTrigg Leslie
Chair and CEO who sold 3,437 shares in an open-market transaction.
